Yi-Hsuan Liu
Overview
Explore the profile of Yi-Hsuan Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
121
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Y, Fan C, Hou J, Cheng Y, Liu Y, Kuo C, et al.
Neuroepidemiology
. 2025 Feb;
:1-19.
PMID: 39904321
Background: Encephalitis can lead to significant disability among survivors. Up-to-date estimates of encephalitis incidence and the risk of postencephalitic epilepsy (PE) are crucial for informing health policy. Methods: We used...
2.
Hansen D, Bixby T, Fixler K, Shea L, Martin J, Brittle C, et al.
Support Care Cancer
. 2025 Jan;
33(2):134.
PMID: 39890679
Purpose: Stem cell transplantation (SCT) is considered standard of care for patients with newly diagnosed multiple myeloma (MM) but is still associated with substantial challenges for patients and caregivers. Given...
3.
Liu Y, Liang J, Chang M, Hung P, Tsai M, Chou I, et al.
Pediatr Neonatol
. 2024 Aug;
PMID: 39187419
Objective: Protocadherin-19 (PCDH19) epilepsy is a rare female restricted epilepsy syndrome with early onset seizures and developmental delay caused by a change or mutation of the PCDH19 gene on the...
4.
Liu Y, Lin Y, Shih L, Lin C, Chang L
Arch Gerontol Geriatr
. 2024 Jul;
127:105583.
PMID: 39059036
Background: The decline of inhibitory in cognitive aging is linked to reduced cognitive and mental capacities in older adults. However, this decline often shows inconsistent clinical presentations, suggesting varied impacts...
5.
Hansen D, Dhakal B, Hamadani M, Dingli D, Jain T, Huff C, et al.
Front Immunol
. 2024 Jun;
15:1405452.
PMID: 38915401
Introduction: Chimeric antigen receptor (CAR) T-cell therapy (CAR T therapy) is a treatment option for patients with relapsed or refractory multiple myeloma that has led to unprecedented treatment outcomes. Among...
6.
Huang C, Tseng Y, Tsai W, Su C, Cheng C, Kao Yang Y, et al.
Infect Dis Ther
. 2024 Jan;
13(2):373-383.
PMID: 38286955
Introduction: Limited studies have evaluated the association between Clostridium difficile infection (CDI) and the duration of proton pump inhibitor (PPI) or histamine H2-receptor blocker (H2RA) use and provided a cutoff...
7.
Hansen D, Liu Y, Ranjan S, Bhandari H, Potluri R, McFarland L, et al.
Cancers (Basel)
. 2023 Dec;
15(24).
PMID: 38136292
Although chimeric antigen receptor (CAR)-T cell therapies are typically administered in the inpatient setting, outpatient administration is rapidly expanding. However, there is limited summarized evidence comparing outcomes between outpatient and...
8.
Hansen D, Bixby T, Fixler K, Shea L, Brittle C, Brunisholz K, et al.
J Patient Exp
. 2023 Sep;
10:23743735231202733.
PMID: 37766811
A qualitative study of the experiences of patients who received autologous stem cell transplant (ASCT) for the treatment of multiple myeloma (MM) was conducted to better understand their MM disease...
9.
Hou J, Liu H, Kuo C, Liu Y, Lin J, Hsieh M, et al.
Front Neurosci
. 2023 Feb;
16:1081580.
PMID: 36817097
Anti-glutamic acid decarboxylase (anti-GAD) antibodies are associated with different types of syndromes. However, few studies have investigated the correlation between anti-GAD antibody titers with clinical severity and outcomes in children...
10.
Lee T, Liu Y, Huang Y, Tang W, Wang Y, Hu S, et al.
Sci Rep
. 2022 Jan;
12(1):801.
PMID: 35039593
This study aims to depict and compare clinical characteristics and risk behavior among groups of individuals using ketamine, polydrugs or smoking cigarette. A total of 185 drug-using participants and 49...